<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="127839">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02023775</url>
  </required_header>
  <id_info>
    <org_study_id>Melody™ France</org_study_id>
    <nct_id>NCT02023775</nct_id>
  </id_info>
  <brief_title>Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™</brief_title>
  <acronym>Melody™ France</acronym>
  <official_title>Non Interventional Study on Pulmonary Valve Replacement by Thranscatheter Pulmonary Valve Melody™</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Bakken Research Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Bakken Research Center</source>
  <oversight_info>
    <authority>France: The Commission nationale de l’informatique et des libertés</authority>
    <authority>France: Haute Autorité de Santé Transparency Commission</authority>
    <authority>France: Conseil National de l'Ordre des Médecins</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, longitudinal, open-label, multicentre, observational, non-comparative national
      study using an exhaustive registry of implantations over a given period.

      This study is requested by French Health Authorities for reimbursement renewal, to maintain
      reimbursement for pulmonary valvular replacement by bioprothesis in approved indication in
      France.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>absence of re-intervention on the pulmonary valve</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>to evaluate the efficacy of the MELODY valve, defined as the absence of re-intervention on the pulmonary valvee</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>rate re-intervention on the valve</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To document the rate re-intervention on the valve during a 60 months follow-up after its implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time period before re-intervention on the valve</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To document the time period before re-intervention on the valve (longevity of the prosthesis), the reasons for re-intervention (stent fracture, leak, stenosis) and the rate of durability (% of implanted valves with malfunction requiring a re-intervention)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient characteristics</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To compare the patient characteristics to the indications of the bioprosthesis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description and time of onset of open surgery after implantation</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Description and time of onset of open surgery after implantation on first implanted patients versus device replacement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>failures of the implantation procedure</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To document the failures of the implantation procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>survival rate at 12, 36, 48 and 60 months</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To document the survival rate at 12, 36, 48 and 60 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of antiplatelet treatment during and after implant</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To describe the frequency of antiplatelet treatment during and after implant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patients' characteristics to indications of the MELODY™ bioprosthesis</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To compare patients' characteristics to indications of the MELODY™ bioprosthesis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>time period before the resumption of professional, university or scholastic activity</measure>
    <time_frame>60 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To document the time period before the resumption of professional, university or scholastic activity</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Right Ventricular Congenital Cardiopathies</condition>
  <arm_group>
    <arm_group_label>Patients implanted with Medtronic Melody valve</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Melody valve implantation</intervention_name>
    <arm_group_label>Patients implanted with Medtronic Melody valve</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        all patients receiving a valve implantation, without exception (exhaustive population)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients requiring pulmonary valvular replacement for correction of right ventricular
             ejection path malfunction (stenosis and/or pulmonary regurgitation).

        Exclusion Criteria:

          -  Patient or legal representative refusal to data collection or processing

          -  Patient unable to guarantee follow-up data collection, in particular for patients
             living abroad
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Younes Boudjemline, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpital des enfants Malades - Necker, 149 rue de Sèvres, 75015 Paris, France</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jérôme Petit, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Chirurgical Marie Lannelongue, 133 avenue de la résistance, 92350 Le Plessis-Robinson, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anaïs Chatagnon</last_name>
    <phone>+33155382941</phone>
    <email>anais.chatagnon@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fanny Wilquin</last_name>
    <phone>+33155386025</phone>
    <email>fanny.wilquin@medtronic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Louis Pradel</name>
      <address>
        <city>Bron</city>
        <zip>69677</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François Sassolas, MD</last_name>
      <email>francois.sassolas@chu-lyon.fr</email>
    </contact>
    <investigator>
      <last_name>François Sassolas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Gabriel Montpied</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-René Lusson, MD</last_name>
      <email>jrlusson@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-René Lusson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centre chirurgical Marie Lannelongue</name>
      <address>
        <city>Le Plessis-Robinson</city>
        <zip>92350</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jérôme Petit, MD</last_name>
      <email>j.petit@ccml.fr</email>
    </contact>
    <investigator>
      <last_name>Jérôme Petit, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cardiologique</name>
      <address>
        <city>Lille</city>
        <zip>59037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François Godart, MD</last_name>
      <email>francois.godart@chru-lille.fr</email>
    </contact>
    <investigator>
      <last_name>François Godart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital de La Timone Enfants</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alain Fraisse, MD</last_name>
      <email>alain.fraisse@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Alain Fraisse, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Laënnec</name>
      <address>
        <city>Nantes</city>
        <zip>44800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Patrice Guérin, MD</last_name>
      <email>patrice.guerin@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Patrice Guérin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital des enfants Malades Necker</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Younes Boudjemline, MD</last_name>
      <email>younes.boudjemline@nck.aphp.fr</email>
    </contact>
    <investigator>
      <last_name>Younes Boudjemline, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Cardiologique du Haut-Lévêque</name>
      <address>
        <city>Pessac</city>
        <zip>33604</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Benoît Thambo, MD</last_name>
      <email>jean-benoit.thambo@chu-bordeaux.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Benoît Thambo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Pasteur</name>
      <address>
        <city>Toulouse</city>
        <zip>31076</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>François Heitz, MD</last_name>
      <email>francois.heitz3@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>François Heitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital des enfants Purpan</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sébastien Hascoët, MD</last_name>
      <email>hascoet.s@chu-toulouse.fr</email>
    </contact>
    <investigator>
      <last_name>Sébastien Hascoët, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 23, 2013</lastchanged_date>
  <firstreceived_date>April 29, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
